• Medicine
  • Published in
    Clinical and experimental…
    2011

Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology II. Safety.

@article{Favalli2011RecommendationsFT,
  title={Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology II. Safety.},
  author={Ennio Giulio Favalli and R Caporali and Luigi Sinigaglia and Nicolo' Pipitone and Irene Miniati and Carlomaurizio Montecucco and Marco Matucci-Cerinic},
  journal={Clinical and experimental rheumatology},
  year={2011},
  volume={29 3 Suppl 66},
  pages={
          S15-27
        }
}
Given the availability of novel biologic agents for the treatment of rheumatoid arthritis (RA), various national scientific societies have developed specific recommendations in order to assist rheumatologists in prescribing these drugs. The Italian Society for Rheumatology (Società Italiana di Reumatologia, SIR) decided to update its recommendations, and, to this end, a systematic literature review was performed and the evidence derived from it was discussed and summarized as expert opinions… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

Biological therapies in rheumatic diseases.

  • La Clinica terapeutica
  • 2013
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 104 REFERENCES

BEG S, LOPEZ-OLIVO MA: Tocilizumab for rheumatoid arthritis

JA SINGH
  • Cochrane Database Syst Rev
  • 2010
VIEW 1 EXCERPT

MÜLLER-LADNER U: Actual status of antiinterleukin-1 therapies in rheumatic diseases

M GEYER
  • Curr Opin Rheumatol
  • 2010